ZWJ Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $85.9M | Buy |
341,420
+3,260
| +1% | +$701K | 2.78% | 7 |
|
|
2026
Q1 | $73.5M | Buy |
338,160
+2,820
| +0.8% | +$626K | 2.65% | 9 |
|
|
2025
Q4 | $76.6M | Sell |
335,340
-2,452
| -0.7% | -$559K | 2.76% | 7 |
|
|
2025
Q3 | $78.2M | Buy |
337,792
+3,805
| +1% | +$775K | 2.76% | 7 |
|
|
2025
Q2 | $62M | Buy |
333,987
+422
| +0.1% | +$78.4K | 2.3% | 10 |
|
|
2025
Q1 | $69.9M | Buy |
333,565
+793
| +0.2% | +$154K | 2.84% | 4 |
|
|
2024
Q4 | $59.1M | Buy |
332,772
+5,887
| +2% | +$1.08M | 2.44% | 9 |
|
|
2024
Q3 | $64.6M | Buy |
326,885
+776
| +0.2% | +$145K | 2.64% | 8 |
|
|
2024
Q2 | $55.9M | Buy |
326,109
+8,330
| +3% | +$1.38M | 2.46% | 9 |
|
|
2024
Q1 | $57.9M | Buy |
317,779
+543
| +0.2% | +$93.6K | 2.63% | 7 |
|
|
2023
Q4 | $49.2M | Buy |
317,236
+561
| +0.2% | +$81.8K | 2.53% | 8 |
|
|
2023
Q3 | $47.2M | Sell |
316,675
-130
| -0% | -$19.1K | 2.62% | 8 |
|
|
2023
Q2 | $42.7M | Buy |
316,805
+23,703
| +8% | +$3.48M | 2.23% | 11 |
|
|
2023
Q1 | $46.7M | Buy |
293,102
+10,189
| +4% | +$1.56M | 2.58% | 7 |
|
|
2022
Q4 | $45.7M | Buy |
282,913
+4,363
| +2% | +$669K | 2.58% | 6 |
|
|
2022
Q3 | $37.4M | Buy |
278,550
+3,376
| +1% | +$484K | 2.35% | 7 |
|
|
2022
Q2 | $42.1M | Buy |
275,174
+110
| +0% | +$16.8K | 2.46% | 7 |
|
|
2022
Q1 | $44.6M | Buy |
275,064
+902
| +0.3% | +$131K | 2.36% | 8 |
|
|
2021
Q4 | $37.1M | Buy |
274,162
+6,980
| +3% | +$825K | 1.9% | 19 |
|
|
2021
Q3 | $28.8M | Buy |
267,182
+8,239
| +3% | +$941K | 1.63% | 22 |
|
|
2021
Q2 | $29.2M | Buy |
258,943
+133,845
| +107% | +$15.1M | 1.69% | 23 |
|
|
2021
Q1 | $13.5M | Buy |
125,098
+83,677
| +202% | +$8.95M | 0.83% | 50 |
|
|
2020
Q4 | $4.44M | Buy |
41,421
+4,758
| +13% | +$457K | 0.3% | 59 |
|
|
2020
Q3 | $3.21M | Sell |
36,663
-1,770
| -5% | -$167K | 0.26% | 59 |
|
|
2020
Q2 | $3.77M | Sell |
38,433
-61,655
| -62% | -$5.43M | 0.33% | 54 |
|
|
2020
Q1 | $7.63M | Buy |
100,088
+871
| +0.9% | +$74.2K | 0.68% | 44 |
|
|
2019
Q4 | $8.79M | Buy |
99,217
+61,531
| +163% | +$5.11M | 0.59% | 53 |
|
|
2019
Q3 | $2.85M | Buy |
37,686
+1,000
| +3% | +$68.6K | 0.22% | 62 |
|
|
2019
Q2 | $2.67M | Buy |
36,686
+6,071
| +20% | +$477K | 0.21% | 65 |
|
|
2019
Q1 | $2.47M | Buy |
30,615
+1,135
| +4% | +$92.9K | 0.2% | 66 |
|
|
2018
Q4 | $2.72M | Buy |
29,480
+314
| +1% | +$27.6K | 0.26% | 64 |
|
|
2018
Q3 | $2.76M | Buy |
29,166
+960
| +3% | +$91K | 0.22% | 61 |
|
|
2018
Q2 | $2.61M | Hold |
28,206
| – | – | 0.23% | 62 |
|
|
2018
Q1 | $2.67M | Sell |
28,206
-5,675
| -17% | -$623K | 0.24% | 61 |
|
|
2017
Q4 | $3.28M | Sell |
33,881
-1,102
| -3% | -$104K | 0.26% | 63 |
|
|
2017
Q3 | $3.11M | Buy |
34,983
+1,442
| +4% | +$110K | 0.24% | 66 |
|
|
2017
Q2 | $2.43M | Sell |
33,541
-4,218
| -11% | -$284K | 0.19% | 72 |
|
|
2017
Q1 | $2.46M | Buy |
37,759
+6,529
| +21% | +$410K | 0.2% | 74 |
|
|
2016
Q4 | $1.96M | Sell |
31,230
-3,669
| -11% | -$224K | 0.19% | 70 |
|
|
2016
Q3 | $2.2M | Sell |
34,899
-445
| -1% | -$28.8K | 0.22% | 68 |
|
|
2016
Q2 | $2.19M | Buy |
35,344
+1,150
| +3% | +$70.1K | 0.22% | 68 |
|
|
2016
Q1 | $1.95M | Sell |
34,194
-75
| -0.2% | -$4.18K | 0.21% | 68 |
|
|
2015
Q4 | $2.03M | Buy |
34,269
+300
| +0.9% | +$17.3K | 0.22% | 73 |
|
|
2015
Q3 | $1.85M | Sell |
33,969
-1,300
| -4% | -$84.6K | 0.21% | 69 |
|
|
2015
Q2 | $2.37M | Buy |
35,269
+800
| +2% | +$52.2K | 0.25% | 70 |
|
|
2015
Q1 | $2.02M | Buy |
34,469
+7,019
| +26% | +$424K | 0.21% | 72 |
|
|
2014
Q4 | $1.8M | Sell |
27,450
-6,821
| -20% | -$430K | 0.18% | 74 |
|
|
2014
Q3 | $1.98M | Buy |
34,271
+1,809
| +6% | +$100K | 0.21% | 74 |
|
|
2014
Q2 | $1.83M | Sell |
32,462
-324
| -1% | -$17K | 0.2% | 74 |
|
|
2014
Q1 | $1.69M | Buy |
32,786
+727
| +2% | +$36.7K | 0.2% | 75 |
|
|
2013
Q4 | $1.69M | Buy |
32,059
+399
| +1% | +$19.6K | 0.19% | 76 |
|
|
2013
Q3 | $1.42M | Sell |
31,660
-11,371
| -26% | -$504K | 0.18% | 73 |
|
|
2013
Q2 | $1.78M | Buy |
+43,031
| New | +$1.88M | 0.24% | 70 |
|
Other funds holding ABBV
ATO
HCM
AAMU
FWCM
AAIS
ZWJ Investment Counsel's ABBV Position: Q2 2026 in Review
ZWJ Investment Counsel increased its AbbVie (ABBV) stake by 0.96% in Q2 2026, buying an estimated $701K and bringing the position to 341,420 shares worth $85.9M. The position accounts for 2.78% of the portfolio, ranked #7.
ZWJ Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,602 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- ZWJ Investment Counsel held 341,420 shares of AbbVie worth $85.9M as of Q2 2026.
- ZWJ Investment Counsel bought 3,260 AbbVie shares in Q2 2026, an estimated $701K.
- AbbVie made up 2.78% of ZWJ Investment Counsel's portfolio in Q2 2026, its #7 holding.
- ZWJ Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 1,602 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on ZWJ Investment Counsel's 13F filing for Q2 2026, filed 16 Jul 2026.